The reduction, which happened between 2008 and 2022, is consistent with the widespread use of the human papillomavirus (HPV) vaccine since it was approved by the FDA in 2006.

The quadrivalent HPV vaccine (Saccharomyces cerevisiae) Gardasil is now approved for men aged 9 to 26 for the prevention of HPV16- and HPV18-associated anal cancer, genital warts (condyloma ...

SB-207 is under clinical development by Pelthos Therapeutics and currently in Phase II for Genital Warts (Condylomata Acuminata). According to GlobalData, Phase II drugs for Genital Warts (Condylomata ...

There are a variety of treatment options for genital warts (condyloma acuminata), a skin condition caused by the human papillomavirus (HPV). Visible genital warts can go away on their own within a ...

Background: Condyloma acuminatum (CA), also known as a genital wart (GW), is a sexually transmitted disease caused by human papillomavirus (HPV). HPV lesions, recurrence tendency, and risk of ...

Warts (condylomata acuminata): These cauliflower-like growths are the most common sign of HPV. They can vary in size and appear on the penis, on the scrotum, or around the anal region, and they ...

Genital warts (condyloma acuminata) are caused by the human papillomavirus (HPV), typically types 6 and 11. There is no treatment for HPV, but treatments for genital warts are available. These ...

Many patients infected with HPV never manifest a condyloma, but they are infectious nonetheless. The most common infectious agents causing condylomata acuminata are low-risk HPV 6 and 11; high-risk ...

Genital Warts (Condyloma Acuminatum) Market The genital warts (condyloma acuminatum) market is predicted to grow from its current value of US$ 1.87 billion in 2023 to US$ 3 billion by 2033, with a ...

Genital warts (condylomata acuminate) are very common. According to 2012 research, there are up to 1 million new cases of genital warts diagnosed each year in the United States.